----
Current ValuationThe current P/E ratio is -1.53, above the reasonable range, cheaper than 4.6% of the time in the past 1 years, and the industry ranks 7/12, the industry Median 9.08.
-1.53xP/E
HK$1.46Stock price
HK$-0.96Earnings per share
-1.53xP/E
Stock priceHK$1.46Earnings per shareHK$-0.96
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- -11.23x
- Typical range
- -15.51x–-2.09x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 9.08x
07142128
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 9.08x
0x10x20x30x40x50x
| Name/Symbol | |||
|---|---|---|---|
02170HKBASECARE-B | -1.82x | 27.39% | HK$364.94M |
02393HKYESTAR HEALTH | -1.57x | -- | HK$151.55M |
00876HKQH BIO PHARMA | -1.53x | -- | HK$151.30M |
08622HKJOYZYME GROUP | -19.58x | -- | HK$112.37M |
01134HKKELFRED | -4.29x | -- | HK$96.00M |
08513HKMAXWIN INT HLDG | -12.65x | -- | HK$31.10M |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
